ArticleBMC genomics2026
Maternal and offspring genome-wide association study of C-reactive protein reveals limited polygenic association with gestational diabetes mellitus.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
15 authors.
Funding
Abstract
backgroundC-reactive protein (CRP) is a well-established biomarker of systemic inflammation. In pregnancy, several studies show association of elevated CRP with gestational diabetes mellitus (GDM). However, the genetic contributions of CRP levels during early pregnancy and their potential association with GDM remain largely understudied. The Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b) provides a unique opportunity to investigate these questions due to its rich design, including early pregnancy biospecimens, genome-wide genotype data, and detailed clinical outcomes across multiple ancestry groups.
resultsWe performed genome-wide association studies (GWAS) of first-trimester CRP levels using maternal (n = 4,326) and offspring (n = 2,140) genotypes from the nuMoM2b cohort. In the European-ancestry maternal sub-cohort of nuMoM2b, three genome-wide significant loci (CRP, LEPR, and HNF1A) were associated with early pregnancy CRP levels, consistent with findings from previous GWAS in non-pregnant populations. Analysis of the full multi-ancestry maternal cohort identified two additional loci (ENSG00000257703 and APOC1) associated with CRP levels. No genome-wide significant associations were detected in the offspring GWAS of CRP levels. Linkage disequilibrium score regression did not detect a significant genetic correlation between CRP and GDM using the nuMoM2b CRP GWAS. In contrast, a significant correlation was observed when using an external large population-based CRP GWAS, suggesting that genetic overlap between CRP and GDM may vary across study contexts. However, Polygenic risk scores for CRP derived from either GWAS source were not significantly associated with GDM risk in the nuMoM2b cohort.
conclusionsThese findings provide insights into the genetic architecture of CRP levels during early pregnancy and illustrate the potential value of pregnancy-specific genomic studies for improving understanding of inflammatory processes relevant to maternal-fetal health. They also highlight the need for larger pregnancy cohorts to better understand the relationship between inflammation and metabolic complications during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.